当前位置:首页 - 行情中心 - 开立医疗(300633) - 财务分析 - 现金流量表

开立医疗

(300633)

  

流通市值:49.42亿  总市值:80.72亿
流通股本:2.60亿   总股本:4.25亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,139,414,943.54573,266,880.832,378,247,8131,453,350,399.53
  收到的税费返还61,423,151.1331,438,328.75186,139,232.83122,791,187.69
  收到其他与经营活动有关的现金54,640,461.1527,503,272.79102,847,426.8544,627,706.64
  经营活动现金流入小计1,255,478,555.82632,208,482.372,667,234,472.681,620,769,293.86
  购买商品、接受劳务支付的现金518,187,873.92288,997,075.651,230,473,490.87813,203,448.6
  支付给职工以及为职工支付的现金547,718,403.79324,133,201.94971,793,144.06713,772,007.99
  支付的各项税费84,879,673.4749,458,134.87148,620,388.14107,463,040.26
  支付其他与经营活动有关的现金211,283,789.68109,404,298.76364,507,015.26367,302,857.01
  经营活动现金流出小计1,362,069,740.86771,992,711.222,715,394,038.332,001,741,353.86
  经营活动产生的现金流量净额-106,591,185.04-139,784,228.85-48,159,565.65-380,972,060
二、投资活动产生的现金流量:
  取得投资收益收到的现金545,119.82306,476.845,753,489.735,629,722.35
  处置固定资产、无形资产和其他长期资产收回的现金净额--129,902.21-
  收到的其他与投资活动有关的现金550,000,000448,000,000784,500,000679,900,000
  投资活动现金流入小计550,545,119.82448,306,476.84790,383,391.94685,529,722.35
  购建固定资产、无形资产和其他长期资产支付的现金61,669,048.6133,619,318.35142,241,842.87101,981,279.26
  支付其他与投资活动有关的现金522,000,000200,000,000856,600,000258,000,000
  投资活动现金流出小计583,669,048.61233,619,318.35998,841,842.87359,981,279.26
  投资活动产生的现金流量净额-33,123,928.79214,687,158.49-208,458,450.93325,548,443.09
三、筹资活动产生的现金流量:
  取得借款收到的现金226,950,758.0828,549,550.39230,677,840.51245,292,590.89
  收到其他与筹资活动有关的现金--7,965,000-
  筹资活动现金流入小计226,950,758.0828,549,550.39238,642,840.51245,292,590.89
  偿还债务支付的现金245,792,212.6861,758,823262,091,846.6283,239,566.97
  分配股利、利润或偿付利息支付的现金78,216,853.47889,284.0947,233,382.0346,344,370
  支付其他与筹资活动有关的现金209,943,409.323,858,034.9919,732,039.0214,533,305.5
  筹资活动现金流出小计533,952,475.4766,506,142.08329,057,267.65344,117,242.47
  筹资活动产生的现金流量净额-307,001,717.39-37,956,591.69-90,414,427.14-98,824,651.58
四、汇率变动对现金及现金等价物的影响-19,093,766.49-10,187,794.592,891,504.89378,972.51
五、现金及现金等价物净增加额-465,810,597.7126,758,543.36-344,140,938.83-153,869,295.98
  加:期初现金及现金等价物余额1,178,420,833.941,178,420,833.941,522,561,772.771,522,561,772.77
  期末现金及现金等价物余额712,610,236.231,205,179,377.31,178,420,833.941,368,692,476.79
补充资料:
  净利润13,776,261.12-197,280,077.3-
  资产减值准备8,836,620.62-54,468,253.27-
  固定资产和投资性房地产折旧43,340,253.91-73,133,742.16-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧43,340,253.91-73,133,742.16-
  无形资产摊销4,089,251.97-11,325,591.29-
  长期待摊费用摊销3,483,075.68-7,501,306.68-
  处置固定资产、无形资产和其他长期资产的损失---30,736.87-
  固定资产报废损失158,380.7-1,209,384.95-
  公允价值变动损失-590,177.8--163,727.82-
  财务费用42,359,727.32-689,246.99-
  投资损失-377,945.08--2,195,770.34-
  递延所得税-15,082,333.14--40,650,586.25-
  其中:递延所得税资产减少-15,082,333.14--40,650,586.25-
  存货的减少-175,691,456.78--286,001,390.68-
  经营性应收项目的减少20,168,944.58--72,759,991.38-
  经营性应付项目的增加-76,799,812.17--13,353,945.58-
  其他17,144,484.71-3,106,143.73-
  现金的期末余额712,610,236.23-1,178,420,833.94-
  减:现金的期初余额1,178,420,833.94-1,522,561,772.77-
  现金及现金等价物的净增加额-465,810,597.71--344,140,938.83-
公告日期2026-08-222026-04-292026-04-172025-10-29
审计意见(境内)标准无保留意见
TOP↑